Answers to the questions

Haemophilus Influenzae B "HIB" Compulsory Vaccination in Infanrix IPV-HIB (Hiberix Component)


"HIB" is an acronym for Haemophilus influenzae b. The designation "influenza" does not imply that the bacterium Haemophilus influenzae is related to influenza virus.

What are the Hiberix vaccines against?

Prior to the identification of the bacterium, diseases with severe course of pulmonary inflammation were detected during an influenza outbreak. The bacterial type b belongs to the class of encapsulated bacteria, specifically human catarrh. In the pharynx, it can be present in asymptomatic conditions for weeks to months, and can spread from person to person with drip infection. Bacterial carriers in children are more common in children under 5 years. A bacterial species without a capsule may be a member of the human throat flora without causing disease. Prior to the introduction of vaccination (1998), H. influenzae b has been the cause of severe life-threatening illnesses in our country under the age of 5 years. Purulent meningitis, epiglottitis, pneumonia, septicemia were the most common causes of otitis media (purulenta otitis media) and maxillary sinusitis (sinusitis maxillaris). In many cases, these diseases were fatal infections. As childhood vaccine vaccination is now over 98%, the disease is a rare occurrence and only patients with non-vaccinated and seriously ill patients (patients with need for chemotherapy, immunodeficiency).

What do you need to know about vaccine?

The vaccine contains the polycribosyl ribitol phosphate (PRP) encapsulating material, an antigen that results in the production of a protective (protective) antibody. This carbohydrate compound (polysaccharide) defines the infectious capacity of the virus, which the immune system responds to by producing antibodies that provide adequate protection against the disease, but does not cause self-infection. In order for the immune system of the most affected age group (under the age of 5) to respond with sufficient antibody production, the polysaccharide capsule is conjugated to a strong, immunomodulatory effect. As a result of the vaccination, the bacterial carrier of the encapsulated Haemophilus influenzae b bacterium is also eliminated, which means that it is impossible for the bacterium to spread from person to person.
Suggestion for extinguishing calendar:
In addition to compulsory vaccination, it is recommended that the vaccine be "recommended" to people with certain serious underlying conditions, up to the age of 5 years. It is of particular importance that vaccinated patients receive their vaccinations before vaccination (with other capsular bacteria: pneumococcal, meningococcal), as they may develop inadequacy. Following treatment with a weakened immune system, congenital immune deficiency, and transplantation of organic bone marrow, it is recommended that the HIB vaccine be administered to individuals above 5 years of age.

What are the contraindications and possible side effects?

Do not vaccinate in flammable conditions. Mild overdose with cataract, antibiotic treatment, but not a barrier to vaccination. If a severe allergic reaction has occurred during the previous vaccination (extremely rare, 1: 1000000), a repeat vaccination cannot be performed.
Possible vaccine reactions:
On the day of vaccination and on the following day, fever may occur, sometimes with fever.
The vaccination site may swell with a couple of minutes after vaccination, and may be warm to the touch, and may be bloody. A child may signal this phenomenon with painful horror, anxiety, and loss of strength. The symptom may persist for hours, sometimes for several days. The following vaccine can be considered a milder reaction. A flame retardant may be used to alleviate the symptoms and to treat the fever.
Do not use a soothing flame retardant and do not vacuum the extinguished limb! Compressions are not suitable for alleviating symptoms, and covering the hair canal can cause infection!